Professor Bradley is the director of Yale’s Health Management Program within the Division of Health Policy and Administration. She is also the director of Global Health Initiatives at the School of Public Health and chairs the Global Health Concentration Committee. Her research focuses on health services, with an emphasis on management and quality improvement. Her work in the U.S. focuses on the quality of hospital care for heart attack patients, as well as the use and quality of hospice services. Bradley also is involved in several projects in international settings, including ones in Ethiopia, Liberia, South Africa, and the United Kingdom, which focus on strengthening health systems. She is a member of the World Economic Forum Global Agenda for Healthcare Systems and the Steering Committee for the Open Educational Resources in Public Health Conference, both of which seek innovative ways to enhance health system delivery in global settings. Bradley is a faculty associate for the American College of Healthcare Executives and a member of Academy Health.

Blog Entries by Elizabeth H. Bradley

Bear Traps and Health Care Reform

Posted September 24, 2009 | 10:45 AM (EST)


The current healthcare reform debates are redefining roles for all involved. Politicians think they are historians, civilians fancy themselves as a legislative body, and media personas suddenly see themselves as newsmakers rather than reporters. I recently joined this trend. By all accounts, I'm an academic, but in the dogged-days of...

Read Post

Paradox and Strategy in Global Health Leadership

Posted June 29, 2009 | 12:54 PM (EST)


Written with Lauren Taylor

From June 15-19, Yale University's new Global Health Leadership Institute (GHLI) held its inaugural conference, bringing together top leaders in global health to inspire leadership and new approaches to strengthening health systems. To many ears, what they heard at the conference may have sounded like contradictions....

Read Post

Health Care Crisis Can't Be Solved by Outsiders Alone

2 Comments | Posted June 16, 2009 | 10:11 AM (EST)


Written with Lauren Taylor

It used to be the case that global health work mandated spending enormous sums of money on disease-focused outcomes. The money went towards supplying anti-retroviral treatment for the HIV, DOTS for those stricken by tuberculosis, and artemisinin combination therapy for the millions who contract malaria...

Read Post